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Z
oonotic disease transmission systems constitute sets of 
interacting species, ranging from pathogens in wildlife 
reservoirs and transmitted directly to humans (1), patho-
gens in wildlife reservoirs and transmitted to humans by 
vectors (2), to pathogens in complex systems of multiple 
interacting deﬁ  nitive hosts, intermediate hosts, and vectors 
(3). Because these systems are so tightly linked to biodi-
versity, studies must include sampling of diverse species. 
Emerging Infectious Diseases journal is replete with such 
studies documenting the circumstances surrounding a dis-
ease case or outbreak. However, in developing these stud-
ies, researchers have been remiss regarding 1 major element 
of documentation of their work. Other elements are docu-
mented carefully. For example, when sequence data are 
extracted, primer sequences are presented in the Materials 
and Methods section, and numbers are given of sequences 
deposited in the GenBank database. Biodiversity samples, 
in contrast, are often identiﬁ  ed cursorily or incompletely, 
and the documentation (i.e., the host or vector animal from 
which the pathogens were isolated) is discarded. I suggest 
to the public health, epidemiology, and disease ecology 
communities that careful biodiversity documentation is 
critical to full description of disease research. As a routine 
part of the research process, voucher specimens should be 
deposited in an appropriate scientiﬁ  c collection, and cata-
log numbers reported in publications, 
Disease studies that lack careful biodiversity docu-
mentation are numerous, even in the recent literature. In the 
August 2009 issue of this journal, I found at least 4 articles 
that report sampling of hosts or vectors, yet make no men-
tion of vouchers (4–7). Quite simply, and with few counter-
examples (8), host and vector information is ignored, as if 
all identiﬁ  cations are perfect and complete and as if nothing 
remains to be learned from further study of the samples.
The reality, however, is quite different. First, technolo-
gies for diagnosis and testing have evolved considerably 
and will continue to evolve, with each iteration providing 
more complete information and insight into the pathogens 
present. The failure to preserve voucher specimens, howev-
er, makes such retesting and improved learning impossible. 
For example, in early studies of ﬁ  loviruses, thousands of 
specimens were tested serologically for evidence of infec-
tion (9), with no positive results (10). However, new tech-
niques would likely recover viral genetic material from 
those same samples (11), which could save time and ex-
pense invested in de novo sampling. Second, much remains 
to be learned from relationships between host population 
genetic structure and pathogen distributions. For example, 
some of the complexity of the distribution of Lassa fever 
depends on the particular lineage of Mastomys rodents 
present (12). Many host and vector groups currently con-
sidered single species are, in reality, complexes of species 
with potential (and possibly variable) epidemiologic im-
portance. Such complexities can be explored only with de-
tailed documentary information regarding which hosts did 
and did not harbor the pathogen.
Finally, and perhaps most urgent, treating biodiver-
sity samples as disposable ignores opportunities to assem-
ble archives of diagnostic samples for future studies. Host 
samples accumulated for 1 purpose could be recycled to 
form a strong basis for future studies of pathogens not yet 
known. Consider, for example, that those same samples 
of mammals from Africa from the early ﬁ  lovirus studies 
could have enabled quick and detailed study of Henipavi-
rus distributions, in contrast to the time and effort it took 
to assemble other samples (13). Similarly, mammal sam-
ples assembled for early virus studies in West Africa (14) 
could have made possible rapid testing and evaluation of 
hosts for subsequent virus emergences in the region. In 
this sense, every biodiverse element collected as part of 
disease studies should be considered as potential key in-
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DOI: 10.3201/eid1602.091241frastructure for future studies, if properly documented and 
preserved (15).
Of course, biologic material that is potentially infect-
ed with dangerous pathogens carries with it some degree 
of responsibility, to ensure that unfortunate accidents do 
not occur. Two general paths are possible: 1) treatment of 
voucher specimen material to inactivate pathogens, such 
as preservation in formalin; or 2) notiﬁ  cation by disease 
specialists to biodiversity specialists of any detections of 
pathogen-positive samples, such as samples that are inac-
tivated or isolated. These steps are crucial, but the ﬁ  rst op-
tion offers a way to avoid problems immediately with little 
extra effort.
My suggestion is not an empty dream but rather an 
open door. The biodiversity science community is fully 
prepared and willing to partner with the disease commu-
nity in this effort. On the most proximate level, biodiversity 
specialists are eager to build scientiﬁ  c reference collections 
and are willing to curate and catalog voucher specimens. 
Vouchers provide permanent specimen identiﬁ  ers  that 
can be reported in publications and used to reference the 
voucher in genomic data bases. Furthermore, biodiversity 
specialists are interested in many of the same geographic 
regions as disease specialists and would welcome opportu-
nities to obtain new specimen material from these regions. 
Finally, the role of pathogens in constraining host evolu-
tion, distribution, and ecology is of increasing interest in 
the biodiversity community (16,17). Many biodiversity re-
searchers are extremely eager to explore new knowledge 
realms with disease specialists. 
Prof Peterson is curator of ornithology in the Biodiversity 
Institute, University of Kansas. His research focuses on the geog-
raphy of species’ distributions as well as on bird-borne pathogens 
such as inﬂ  uenza.
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